Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.225 USD | +2.06% | +1.36% | -3.46% |
May. 15 | Compugen Names David Silberman CFO | MT |
May. 13 | Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Chief Financial Officer, Effective July 12, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.46% | 88.57M | |
+49.98% | 54.63B | |
-5.96% | 39.92B | |
+36.84% | 38.82B | |
+14.20% | 26.86B | |
-11.17% | 26.22B | |
-21.87% | 18.78B | |
+26.83% | 12.21B | |
+1.74% | 12.16B | |
+28.03% | 11.94B |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Oramed Pharmaceuticals Secures US Patent for Diabetes Combination Therapy